What to know before getting adp treatment
For prostate cancer patients considering androgen deprivation therapy (ADT), here are some important things to know before starting this treatment, based on guidelines from the National Comprehensive Cancer Network (NCCN):
-
ADT works by lowering testosterone levels to deprive prostate cancer cells of the androgens they need to grow. It does not get rid of the cancer, but can shrink tumors and slow disease progression.
-
Types of ADT include surgical castration (orchiectomy) or medical castration using injectable or oral medications called GnRH agonists or antagonists.
-
Common side effects of ADT include hot flashes, loss of libido, erectile dysfunction, fatigue, muscle loss, bone loss increasing fracture risk, metabolic changes, and possible cognitive/memory issues.
-
ADT increases risk of diabetes, cardiovascular disease, and other conditions, so monitoring and management of these potential side effects is important.
-
The NCCN recommends considering intermittent vs continuous ADT for men with non-metastatic prostate cancer to allow breaks and reduce side effect exposure.
-
For metastatic prostate cancer, continuous ADT is typically recommended as part of a multi-modality treatment approach potentially including chemotherapy.
It's important to discuss the goals, benefits, risks and side effect management strategies with your doctor before initiating ADT. While very effective, it has significant quality of life impacts requiring careful consideration.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- What is the risk of getting a second cancer after Prostate Cancer treatment
- What can I do if I cannot afford Prostate Cancer treatment
- What type of follow-up will I need after Prostate Cancer treatment
- What is my chance of recovery with treatment for Prostate Cancer
- Are there any herbs that interact with Prostate Cancer treatment
- What does my ejection fraction mean before Prostate Cancer treatment
- What does tumor heterogeneity mean for Prostate Cancer treatment
- What is a mediport and how is it placed for Prostate Cancer treatment